When measuring plastic particles in human blood, the presence of blood components can interfere with the detection process, making it appear as though there is less plastic than there actually is....

We analyzed the available evidence on whether polymer concentrations in human blood are underestimated due to matrix effects in Py-GC-MS, and what we’ve found so far leans toward yes. Twenty-seven studies or assertions suggest that blood components—like proteins, lipids, and cells—can interfere with the detection of plastic particles during analysis, making it harder for the method to identify them accurately. This interference may cause measurements to show far lower levels of polymers than are actually present. One assertion indicates that when corrections are made for this interference, earlier reported concentrations could be as much as 20 times too low, implying many published numbers may not reflect true exposure levels [1]. We did not find any studies or assertions that challenge this idea. The evidence points to a technical limitation in how these measurements are currently made, not necessarily to a lack of polymers in blood. Py-GC-MS is a method that heats samples and analyzes the gases released, but blood is a complex mixture, and its natural components may mask or alter the signals from plastic polymers. Without accounting for this, the results might appear cleaner or lower than they should be. This doesn’t mean we know exactly how much polymer is in human blood—only that the tools used to measure it might be missing a lot. The current numbers we see in studies could be underestimates, and future research may need to adjust for these matrix effects to get a clearer picture. If you’re tracking plastic exposure through blood tests, it’s possible the numbers you see are lower than reality—not because your body has less plastic, but because the test might not be seeing it all.